• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027.一项关于阴道环预防HIV依从性和可接受性的混合方法研究:MTN - 027的行为学结果
AIDS Behav. 2020 Feb;24(2):607-616. doi: 10.1007/s10461-019-02457-0.
2
Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States.美国孕妇对基于抗逆转录病毒的阴道杀微生物剂的可接受性和依从性。
AIDS Behav. 2018 Feb;22(2):402-411. doi: 10.1007/s10461-017-1811-9.
3
User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences.用户评估为阴道内环作为药物输送平台提供了前景:一项关于可接受性和使用经验的混合方法研究。
PLoS One. 2018 May 14;13(5):e0197269. doi: 10.1371/journal.pone.0197269. eCollection 2018.
4
Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.通过设计用于预防 HIV-1 的 pod-intravaginal 环来输送单一、双重和三重抗逆转录病毒药物配方的安全性和药代动力学:一项 I 期试验。
PLoS Med. 2018 Sep 28;15(9):e1002655. doi: 10.1371/journal.pmed.1002655. eCollection 2018 Sep.
5
Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.巴布亚新几内亚的阴道内性行为及杀微生物剂可接受性:对中等流行率地区艾滋病毒预防工作的启示
BMC Res Notes. 2012 Nov 1;5:613. doi: 10.1186/1756-0500-5-613.
6
Sharing Objective Measures of Adherence to a Vaginal Microbicide Promotes Candor About Actual Use and Bolsters Motivation to Prevent HIV.分享阴道杀菌剂依从性的客观测量方法有助于坦诚讨论实际使用情况并增强预防艾滋病毒的动机。
AIDS Behav. 2021 Mar;25(3):721-731. doi: 10.1007/s10461-020-03026-6. Epub 2020 Sep 12.
7
Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".男性伴侣对女性参与艾滋病病毒预防试验及使用暴露前预防药物的影响:“理解”的重要性
AIDS Behav. 2015 May;19(5):784-93. doi: 10.1007/s10461-014-0950-5.
8
Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya.在肯尼亚基苏木,少女的性特征、感染艾滋病毒的风险以及她们参与杀微生物剂研究的潜在可接受性。
Sex Health. 2008 Dec;5(4):339-46. doi: 10.1071/sh08011.
9
An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.加纳农村地区女性对预防 HIV 的阴道杀微生物剂的可接受性评估。
BMC Womens Health. 2012 Nov 1;12:40. doi: 10.1186/1472-6874-12-40.
10
Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India.可接受性和依从性:印度浦那一项候选阴道杀微生物剂“Praneem 多草药片”的 II 期研究结果。
Trans R Soc Trop Med Hyg. 2010 Jun;104(6):412-5. doi: 10.1016/j.trstmh.2009.12.007. Epub 2010 Jan 22.

引用本文的文献

1
Preferred product attributes of a multipurpose vaginal ring: Findings from a phase 1 trial.多功能阴道环的优选产品属性:1期试验结果
Front Reprod Health. 2023 Mar 30;5:1148134. doi: 10.3389/frph.2023.1148134. eCollection 2023.
2
Acceptability of PC-1005 Gel Administered Rectally to HIV-1 Seronegative Adults at Three Different Volume Levels (MTN-037).PC-1005 凝胶经直肠给药在三个不同容量水平下用于 HIV-1 血清阴性成人的可接受性(MTN-037)。
AIDS Educ Prev. 2022 Aug;34(4):257-271. doi: 10.1521/aeap.2022.34.4.257.
3
Users' Preferred Characteristics of Vaginal Rings for HIV Prevention: A Qualitative Analysis of Two Phase I Trials.用户对用于预防 HIV 的阴道环的偏好特征:两项 I 期临床试验的定性分析。
AIDS Res Hum Retroviruses. 2022 Apr;38(4):313-326. doi: 10.1089/AID.2021.0077. Epub 2022 Feb 11.
4
Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial.接受度和偏好:1 个月和 3 个月阴道环在预防 HIV-1 风险中的比较:一项 1 期试验中的参与者。
J Womens Health (Larchmt). 2022 Jul;31(7):1029-1039. doi: 10.1089/jwh.2021.0121. Epub 2021 Oct 19.
5
Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world.阴道环可接受性:来自世界各地的阴道环使用体验的系统评价和荟萃分析。
Contraception. 2022 Feb;106:16-33. doi: 10.1016/j.contraception.2021.10.001. Epub 2021 Oct 10.
6
Topical delivery of long-acting antiretrovirals to prevent HIV acquisition.长效抗逆转录病毒经皮给药预防艾滋病病毒感染。
Curr Opin HIV AIDS. 2020 Jan;15(1):42-48. doi: 10.1097/COH.0000000000000598.

本文引用的文献

1
Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women.美国绝经后女性中地蒽酚阴道环的 2a 期安全性、药代动力学和可接受性。
Clin Infect Dis. 2019 Mar 19;68(7):1144-1151. doi: 10.1093/cid/ciy654.
2
Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048.含不同剂量维立西罗(MK-4176)和 MK-2048 的 2 个阴道环的 1 期药代动力学试验。
Clin Infect Dis. 2019 Mar 19;68(7):1129-1135. doi: 10.1093/cid/ciy652.
3
Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings.MK-2048/Vicriviroc(MK-4176)/MK-2048A 阴道环的 1 期安全性和药代动力学研究。
Clin Infect Dis. 2019 Mar 19;68(7):1136-1143. doi: 10.1093/cid/ciy653.
4
Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE.阴道环在 3 期杀微生物剂试验中的使用:ASPIRE 中客观测量与自我报告的不依从性比较。
AIDS Behav. 2019 Feb;23(2):504-512. doi: 10.1007/s10461-018-2261-8.
5
Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results.不依从双汰芝阴道环的原因:客观药物水平结果的叙述性解释。
AIDS. 2018 Jul 17;32(11):1517-1525. doi: 10.1097/QAD.0000000000001868.
6
There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes.可能会有出血:关于女性对避孕引起的月经出血变化反应的范围综述。
Reprod Health. 2018 Jun 26;15(1):114. doi: 10.1186/s12978-018-0561-0.
7
Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex.在一项艾滋病毒预防临床试验中,地蒽酚阴道环对女性性体验和亲密伴侣关系的影响:管理环检测和激情性爱。
AIDS Behav. 2018 Feb;22(2):437-446. doi: 10.1007/s10461-017-1977-1.
8
Acceptability and use of a dapivirine vaginal ring in a phase III trial.达匹韦林阴道环在一项III期试验中的可接受性及使用情况。
AIDS. 2017 May 15;31(8):1159-1167. doi: 10.1097/QAD.0000000000001452.
9
Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women.双汰芝阴道环预防女性艾滋病的安全性和有效性。
N Engl J Med. 2016 Dec 1;375(22):2133-2143. doi: 10.1056/NEJMoa1602046.
10
Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa.在撒哈拉以南非洲多个国家开展的一项杀微生物剂临床试验中,达匹韦林阴道环的安全性、可接受性及依从性
PLoS One. 2016 Mar 10;11(3):e0147743. doi: 10.1371/journal.pone.0147743. eCollection 2016.

一项关于阴道环预防HIV依从性和可接受性的混合方法研究:MTN - 027的行为学结果

A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027.

作者信息

Bauermeister José A, Golinkoff Jesse M, Carballo-Diéguez Alex, Giguere Rebecca, López Daniela, Hoesley Craig J, Chen Beatrice A, Anderson Peter, Dezzutti Charlene S, Strizki Julie, Sprinkle Carol, Heard Faye, Hall Wayne, Jacobson Cindy, Berthiaume Jennifer, Mayo Ashley, Richardson Barbra A, Piper Jeanna

机构信息

School of Nursing, University of Pennsylvania, 418 Curie Blvd., Suite 222L, Philadelphia, PA, 19104, USA.

Department of Psychiatry, Columbia University, New York, USA.

出版信息

AIDS Behav. 2020 Feb;24(2):607-616. doi: 10.1007/s10461-019-02457-0.

DOI:10.1007/s10461-019-02457-0
PMID:30877580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6745293/
Abstract

Intravaginal rings (IVR) containing antiretroviral drugs are a promising method for HIV prevention. We triangulated quantitative and qualitative assessments to evaluate the acceptability of four IVRs used continuously for 28 days as part of a Phase I trial (N = 48 HIV-negative women; ages 18-45). Adherence was high throughout the trial, yet 30% of participants reported involuntary IVR expulsions followed by re-insertion. Most participants (93.6%) felt comfortable with the IVR being inside their body. Participants reported liking the IVR more (36.2%) or the same amount (55.3%) since starting the study. When given the option of choosing between the IVR and/or a male condom for HIV-prevention, most reported preferring the IVR (n = 29, 63.0%), and over a quarter of the sample reported liking them equally (n = 12, 26.1%). We observed no differences in IVR acceptability across the study arms. High adherence and acceptability underscores the promise of an IVR as a female-controlled, sustained mechanism for HIV prevention.

摘要

含有抗逆转录病毒药物的阴道环(IVR)是一种很有前景的HIV预防方法。作为一项I期试验的一部分(N = 48名HIV阴性女性;年龄18 - 45岁),我们采用定量和定性评估相结合的方法,来评估连续使用28天的四种阴道环的可接受性。在整个试验过程中依从性很高,但30%的参与者报告有阴道环非自愿排出并随后重新插入的情况。大多数参与者(93.6%)对阴道环在体内的情况感觉舒适。自开始研究以来,更多参与者(36.2%)或同等比例(55.3%)的参与者表示更喜欢阴道环。当被问及在阴道环和/或男用避孕套之间选择用于HIV预防时,大多数人报告更喜欢阴道环(n = 29,63.0%),超过四分之一的样本报告同样喜欢两者(n = 12,26.1%)。我们观察到各研究组在阴道环可接受性方面没有差异。高依从性和可接受性凸显了阴道环作为一种女性可控的、持续的HIV预防机制的前景。